— Know what they know.
Not Investment Advice
Also trades as: SEZI.ST (STO) · $vol 0M

SNZZF OTC

Senzime AB (publ)
1W: +9.2% 1M: -28.8% 3M: -40.5% YTD: -47.4% 1Y: -59.3% 3Y: -70.0% 5Y: -89.8%
$0.28
+0.00 (+0.00%)
 
OTC · Healthcare · Medical - Devices · Tech Score Sell · Power 39 · $44.8M mcap · 73M float · 0.028% daily turnover · Short 94% of daily vol

Income Trends

Revenue
$104M +77.4% ▲
5Y CAGR: +61.9%
Gross Profit
$31M +54.6% ▲
Operating Income
-$121M +2.7% ▲
Net Income
-$137M -15.5% ▼
EPS (Diluted)
$-0.92 +3.2% ▲
EBITDA
-$96M -0.9% ▼

Profit Margins

Year-over-Year Growth

View Full Income Statement
Line ItemFY2021FY2022FY2023FY2024FY2025
Revenue$11M$14M$36M$58M$104M
YoY Growth+17.6%+27.8%+154.8%+63.6%+77.4%
Cost of Revenue$16M$18M$27M$38M$73M
Gross Profit-$5M-$4M$8M$20M$31M
Gross Margin-44.8%-31.3%23.3%34.4%30.0%
R&D Expenses$13M$19M$19M$22M$23M
SG&A Expenses$68M$114M$123M$131M$129M
Operating Expenses$80M$134M$146M$144M$152M
Operating Income-$84M-$134M-$137M-$124M-$121M
Operating Margin-766.8%-954.1%-384.2%-212.1%-116.3%
Interest Expense$79K$430K$798K$1M$17M
Income Before Tax-$84M-$134M-$137M-$123M-$139M
Tax Expense-$2M-$2M-$3M-$4M-$2M
Net Income-$82M-$133M-$134M-$119M-$137M
Net Margin-748.1%-945.6%-375.2%-203.0%-132.1%
EPS (Diluted)$-1.30$-1.96$-1.45$-0.95$-0.92
EBITDA-$73M-$120M-$116M-$96M-$96M
Shares Outstanding63M68M92M125M147M

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms